Advisor Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $1.45M | Sell |
11,263
-974
| -8% | -$126K | 0.01% | 982 |
|
|
2019
Q3 | $923K | Sell |
12,237
-9,056
| -43% | -$683K | 0.01% | 1187 |
|
|
2019
Q2 | $3.24M | Buy |
21,293
+58
| +0.3% | +$8.81K | 0.02% | 564 |
|
|
2019
Q1 | $2.53M | Buy |
21,235
+698
| +3% | +$83.2K | 0.02% | 634 |
|
|
2018
Q4 | $2.24M | Sell |
20,537
-6,058
| -23% | -$661K | 0.02% | 594 |
|
|
2018
Q3 | $4.3M | Buy |
26,595
+8,302
| +45% | +$1.34M | 0.04% | 366 |
|
|
2018
Q2 | $2.42M | Buy |
18,293
+684
| +4% | +$90.5K | 0.03% | 482 |
|
|
2018
Q1 | $1.3M | Sell |
17,609
-2,124
| -11% | -$157K | 0.02% | 739 |
|
|
2017
Q4 | $1.1M | Buy |
19,733
+3,236
| +20% | +$180K | 0.01% | 837 |
|
|
2017
Q3 | $748K | Buy |
16,497
+6,095
| +59% | +$276K | 0.01% | 979 |
|
|
2017
Q2 | $351K | Buy |
10,402
+326
| +3% | +$11K | 0.01% | 1370 |
|
|
2017
Q1 | $298K | Buy |
10,076
+315
| +3% | +$9.32K | 0.01% | 1387 |
|
|
2016
Q4 | $267K | Buy |
9,761
+67
| +0.7% | +$1.83K | 0.01% | 1368 |
|
|
2016
Q3 | $595K | Buy |
9,694
+1,534
| +19% | +$94.2K | 0.01% | 879 |
|
|
2016
Q2 | $154K | Buy |
+8,160
| New | +$154K | ﹤0.01% | 1632 |
|